Second line, salvage and emerging treatments for HER2+ disease

Date 10 October 2016
Event ESMO 2016 Congress
Session HER2+ advanced breast cancer: A few more questions and many more answers
Topics Anticancer Agents
Breast Cancer
Biological Therapy
Presenter Javier Cortes Castan
Authors J. Cortes Castan
  • Oncology, Hospital Universitario Ramon y Cajal, 28031 - Madrid/ES